You are here: Industry Insights > American Regent

News List

American Regent Announces CEO Transition for 2021 americanpharmaceuticalreview
November 25, 2020
American Regent, a Daiichi Sankyo Group company, announced Ken Keller, currently serving as the company's President and CEO, is transitioning to a new role as the Global Head of Oncology Business at Daiichi Sankyo, effective April 1, 2021.
American Regent Introduces Estradiol Valerate Injection, USP americanpharmaceuticalreview
June 15, 2020
American Regent has announced the introduction and availability of Estradiol Valerate Injection, USP – AO Rated and therapeutically equivalent to Delestrogen®.
American Regent Expands API Ops contractpharma
April 02, 2020
American Regent, a U.S. manufacturer of pharmaceuticals with manufacturing sites in New York and Ohio, will acquire Daiichi Sankyo Altkirch SARL.
American Regent Announces Launch, Availability of Selenious Acid Injection, USP americanpharmaceuticalreview
July 16, 2019
American Regent has announced the introduction of Selenious Acid Injection, USP.
American Regent Announces the Re-Introduction of Aminocaproic Acid Injection, USP americanpharmaceuticalreview
March 05, 2019
American Regent announced the re-introduction of Aminocaproic Acid Injection, USP, a therapeutically equivalent generic alternative to Amicar®.
Luitpold Pharmaceuticals Renamed American Regent americanpharmaceuticalreview
January 03, 2019
Luitpold Pharmaceuticals announced it changed its legal name to American Regent, Inc. effective January 2, 2019. The name change follows consolidation of two subsidiaries into Luitpold to streamline operations....